A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial

Conditions: Long COVID-19 Syndrome; Chronic Fatigue Syndrome Interventions: Drug: Fluvoxamine Maleate 100 MG; Drug: Placebo; Drug: Metformin Extended Release Oral Tablet Sponsors: Cardresearch Recruiting

https://clinicaltrials.gov/study/NCT06128967

Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials